These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 36471375)

  • 21. Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism.
    Dashty M; Motazacker MM; Levels J; de Vries M; Mahmoudi M; Peppelenbosch MP; Rezaee F
    Thromb Haemost; 2014 Mar; 111(3):518-30. PubMed ID: 24500811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein.
    Kinoshita M; Arai H; Fukasawa M; Watanabe T; Tsukamoto K; Hashimoto Y; Inoue K; Kurokawa K; Teramoto T
    J Lipid Res; 1993 Feb; 34(2):261-8. PubMed ID: 8429260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
    Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
    Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
    Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycation of apolipoprotein C1 impairs its CETP inhibitory property: pathophysiological relevance in patients with type 1 and type 2 diabetes.
    Bouillet B; Gautier T; Blache D; Pais de Barros JP; Duvillard L; Petit JM; Lagrost L; Vergès B
    Diabetes Care; 2014 Apr; 37(4):1148-56. PubMed ID: 24574346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes.
    Elchebly M; Pulcini T; Porokhov B; Berthezene F; Ponsin G
    Eur J Clin Invest; 1996 Mar; 26(3):216-23. PubMed ID: 8904350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.
    Masson D; Pais de Barros JP; Zak Z; Gautier T; Le Guern N; Assem M; Chisholm JW; Paterniti JR; Lagrost L
    J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes.
    Dullaart RP; de Vries R; Kwakernaak AJ; Perton F; Dallinga-Thie GM
    Eur J Clin Invest; 2015 Jan; 45(1):36-44. PubMed ID: 25402623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
    J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
    Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
    Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in physiological lipoprotein metabolism.
    Ramasamy I
    Clin Chem Lab Med; 2014 Dec; 52(12):1695-727. PubMed ID: 23940067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
    Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
    Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.